Cerebrovascular Disorders Clinical Trial
Official title:
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke (EXTEND-AGNES TNK)
Multicentre, prospective, Multi-arm Multi-stage (MAMS) seamless phase 2b/3 interventional randomized placebo-controlled double-blinded parallel-assignment (2 arms with 1:1 randomization) efficacy and safety trial to test intra-arterial tenecteplase at the completion of thrombectomy versus best practice in participants with anterior circulation LVO receiving mechanical thrombectomy within 24 hours of symptoms onset.
Status | Not yet recruiting |
Enrollment | 462 |
Est. completion date | November 30, 2027 |
Est. primary completion date | August 30, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult participants (age=18 years) presenting with ischemic stroke with arterial LVO on CT/MR Angiogram of the intracranial internal carotid or middle cerebral artery (MCA) first segment (M1) or proximal second segment (M2) committed to thrombectomy using standard criteria within 24 hours of onset: - For 0-6 hours of symptom onset: Presence of arterial occlusion as defined above and ASPECTS=3 on NCCT - For 6-24 hours of symptom onset: Additional imaging criteria on CTP or MRI perfusion of core volume <100ml. - Qualifying CT/MR within 4hrs of randomisation (repeat CT for transferred participants required if >4hr) - Pre-stroke Modified Rankin Scale (mRS) score of =2 (mild pre-existing disability permitted) - Local legal requirements for consent have been satisfied. Exclusion Criteria: - Intracranial hemorrhage identified by CT or MRI - ASPECTS 0-2 on NCCT - CTP or MRI perfusion ischemic core volume >100ml if presenting within 6-24 hours from symptoms onset - Anticipated endovascular stenting required for intracranial or extracranial atherosclerotic stenosis/occlusion. - More than six retrieval attempts in the same vessel - Alteplase being infused within 30 minutes (~5x half-life) of anticipated trial drug administration - Contraindication to imaging with contrast agents - Any condition (eg.mid-arterial phase early venous filling) that in the judgment of investigators could impose hazards if study therapy is initiated - Pregnant women. - Current participation in another intervention research study that includes experimental interventions beyond standard-of-care. - Anticoagulation. INR =1.7 if on warfarin, and dabigatran reversal by idarucizumab are permitted. - Other standard contraindications to thrombolysis apart from time window. - Known terminal illness such that the participants would not be expected to survive a year. - Planned withdrawal of care or comfort care measures. |
Country | Name | City | State |
---|---|---|---|
Australia | Royal Adelaide Hospital | Adelaide | |
Australia | Princess Alexandra Hospital | Brisbane | |
Australia | Royal Brisbane and Women's Hospital | Brisbane | |
Australia | Canberra Hospital | Canberra | |
Australia | Alfred Hospital | Melbourne | |
Australia | Austin Hospital | Melbourne | |
Australia | Monash Medical Centre | Melbourne | |
Australia | Royal Melbourne Hospital | Melbourne | |
Australia | John Hunter Hospital | Newcastle | |
Australia | Fiona Stanley Hospital | Perth | |
Australia | Liverpool Hospital | Sydney | |
Australia | Royal North Shore Hospital | Sydney |
Lead Sponsor | Collaborator |
---|---|
University of Melbourne |
Australia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Early Neurological Improvement (Phase 2b) | Proportion of participants with Early Neurological Improvement (ENI) defined as NIHSS reduction>4 | 24-36 hours from time of randomisation | |
Primary | Functional independence (Phase 3) | Proportion of participants with Modified Rankin Scale (mRS) 0-2 (functional independence) | 3 months | |
Secondary | Functional improvement | Reduction of = 1 mRS category (ordinal analysis merging mRS categories 5-6) | 3 months | |
Secondary | Infarct growth | Infarct growth volume on follow-up MRI or CT | 24 hours | |
Secondary | No-reflow | Proportion of participants with radiological no-reflow on MR perfusion or CTP | 24 hours | |
Secondary | Symptomatic Intracerebral Hemorrhage | Proportion of participants with sICH defined as parenchymal haematoma type 2 (PH2) or SAH/IVH within 36 hours combined with neurological deterioration leading to an increase of NIHSS =4 from baseline or leading to death | 36 hours | |
Secondary | All cause mortality | Proportion of participants with death due to any cause | 3 months | |
Secondary | Quality of life assessment on EQ-5D | EQ-5D score | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03239847 -
Cost Effectiveness of the EndoPhys Pressure Sensing Access System vs. Radial A-line for Intra-operative Blood Pressure Monitoring
|
N/A | |
Recruiting |
NCT03544801 -
Renji Cerebral Small Vessel Disease Corhort Study
|
||
Recruiting |
NCT06010823 -
Safety and Efficacy Evaluation of the Robotic Enhanced Error Training of Upper Limb Function in Post-stroke and Post TBI Participants
|
N/A | |
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Recruiting |
NCT02472028 -
Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals
|
Phase 4 | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Active, not recruiting |
NCT01555411 -
Akershus Cardiac Examination (ACE) 1950 Study
|
||
Completed |
NCT01304576 -
Orientation Agnosia: Clinical and Anatomical Study
|
N/A | |
Completed |
NCT00049920 -
The ARIC MRI Study
|
N/A | |
Completed |
NCT00049894 -
Predictors of Recurrent Stroke in the PROGRESS Study
|
N/A | |
Completed |
NCT00059293 -
Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
|
||
Completed |
NCT00005562 -
Coronary Artery Calcium, Exercise Tests, and CHD Outcome
|
N/A | |
Completed |
NCT00005395 -
Honolulu Heart Program-Study of Stroke and Dementia
|
N/A | |
Completed |
NCT00000479 -
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
|
Phase 3 | |
Completed |
NCT00005140 -
Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago
|
N/A | |
Enrolling by invitation |
NCT00005485 -
The Jackson Heart Study of Cardiovascular Disease Among African Americans
|
||
Recruiting |
NCT06275113 -
BRING-UP Prevention
|
||
Completed |
NCT02702635 -
Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging
|
N/A | |
Recruiting |
NCT04336852 -
Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function
|
N/A | |
Completed |
NCT03994822 -
pRESET for Occlusive Stroke Treatment
|
N/A |